MET and colorectal carcinoma: A limitation of our study was the small sample size of our pilot study, and a larger prospective study is planned to assess c-MET expression in stage II/III CRC, using both MET RNA ISH and IHC analysis of tumor budding foci, invasive front and central tumor and correlate with patient outcome.